Page last updated: 2024-09-03

mk 912 and Emesis

mk 912 has been researched along with Emesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chan, CC; Jolicoeur, P; Lachance, N; Rasori, R; Robichaud, A; Savoie, C; Stamatiou, PB	1

Other Studies

1 other study(ies) available for mk 912 and Emesis

Article	Year
Assessing the emetic potential of PDE4 inhibitors in rats. British journal of pharmacology, 2002, Volume: 135, Issue:1 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adjuvants, Anesthesia; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Male; Pentobarbital; Phosphodiesterase Inhibitors; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Neurokinin-3; Substance P; Vomiting	2002

Article

Year

Assessing the emetic potential of PDE4 inhibitors in rats.

British journal of pharmacology, 2002, Volume: 135, Issue:1

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adjuvants, Anesthesia; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 4; Dose-Response Relationship, Drug; Male; Pentobarbital; Phosphodiesterase Inhibitors; Quinolizines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Neurokinin-3; Substance P; Vomiting

2002